<?xml version="1.0"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Journal of Natural Sciences Research</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Journal of Natural Sciences Research</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Журнал естественнонаучных исследований</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2500-0489</issn>
   <issn publication-format="online">2500-0489</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">85249</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>Медицинские науки</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>MEDICINE SCIENCE</subject>
    </subj-group>
    <subj-group>
     <subject>Медицинские науки</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">Methodological approaches to conducting pharmacological studies</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Методологические подходы к проведению фармакологических исследований</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Ляшев</surname>
       <given-names>А. Ю.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Lyashev</surname>
       <given-names>A. Yu.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Маль</surname>
       <given-names>Г. С.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Mal</surname>
       <given-names>G. S.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Пыжова</surname>
       <given-names>О. В.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Pyzhova</surname>
       <given-names>O. V.</given-names>
      </name>
     </name-alternatives>
     <bio xml:lang="ru">
      <p>кандидат философских наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>candidate of philosophical sciences;</p>
     </bio>
     <xref ref-type="aff" rid="aff-3"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">НИИ экспериментальной медицины</institution>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Research Institution of Experimental Medicine</institution>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Курский государственный медицинский университет</institution>
    </aff>
    <aff>
     <institution xml:lang="en">Kursk State Medical University</institution>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-3">
    <aff>
     <institution xml:lang="ru">Курский государственный медицинский университет</institution>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Kursk State Medical University</institution>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2024-07-09T15:49:24+03:00">
    <day>09</day>
    <month>07</month>
    <year>2024</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2024-07-09T15:49:24+03:00">
    <day>09</day>
    <month>07</month>
    <year>2024</year>
   </pub-date>
   <volume>9</volume>
   <issue>2</issue>
   <fpage>65</fpage>
   <lpage>70</lpage>
   <history>
    <date date-type="received" iso-8601-date="2024-03-22T00:00:00+03:00">
     <day>22</day>
     <month>03</month>
     <year>2024</year>
    </date>
   </history>
   <self-uri xlink:href="https://zh-szf.ru/en/nauka/article/85249/view">https://zh-szf.ru/en/nauka/article/85249/view</self-uri>
   <abstract xml:lang="ru">
    <p>В статье рассматривается специфика методологических подходов к проведению фармакологических исследований, рассмотрены особенности организации доклинических исследований новых фармакологических препаратов, задачей которых является анализ фармакологической активности, фармакокинетических и токсикологических свойств действующего вещества и лекарственной формы. В статье подчеркивается, что развитие медицинской науки, внедрение новых методов лечения заболеваний человека настоятельно требуют поиска новых эффективных фармакологических препаратов. Учитывая социальную значимость этой сферы, ее этико-правовое регулирование государством является неотъемлемой частью успешного развития на благо общества.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>The article discusses the specifics of methodological approaches to pharmacological studies, considers the peculiarities of organizing preclinical studies of new pharmacological preparations, the task of which is to analyze the pharmacological activity, pharmacokinetic and toxicological properties of the active substance and the dosage form. The article emphasizes that the development of medical science, the introduction of new methods of treating human diseases strongly require the search for new effective pharmacological drugs. Taking into consideration the social significance of the problem under discussion, it goes without saying that ethical and legal regulation of this sphere by the state is an integral part of the successful development for the benefit of the society.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>методология; фармакология; доклинические и клинические исследования; лекарственные препараты; комбинированные препараты</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>methodology; pharmacology; preclinical and clinical studies; medications; combination drugs</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ануфриева А.Г.. Методы и методология научного познания [Текст] / А.Г. Ануфриева, К.А. Головин, А.Б. Копылов //  Известия Тульского государственного университета. Технические науки.- 2021.- Вып. 11.- С. 279-283. URL: https://cyberleninka.ru/article/n/metody-i-metodologiya-nauchnogo-poznaniya/viewer.</mixed-citation>
     <mixed-citation xml:lang="en">Anufrieva A.G.. Metody i metodologiya nauchnogo poznaniya [Tekst] / A.G. Anufrieva, K.A. Golovin, A.B. Kopylov // Izvestiya Tul'skogo gosudarstvennogo universiteta. Tehnicheskie nauki.- 2021.- Vyp. 11.- S. 279-283. URL: https://cyberleninka.ru/article/n/metody-i-metodologiya-nauchnogopoznaniya/viewer.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Васильев А.Н. Качественные доклинические исследования – необходимый этап разработки и внедрения в клиническую практику новых лекарственных препаратов [Текст] / А.Н. Васильев // Антибиотики и химиотерапия.- 2012.- Т. 57.- № 1-2.- С. 41-49. URL: https://www.antibiotics-chemotherapy.ru/jour/article/view/421.</mixed-citation>
     <mixed-citation xml:lang="en">Vasil'ev A.N. Kachestvennye doklinicheskie issledovaniya – neobhodimyy etap razrabotki i vnedreniya v klinicheskuyu praktiku novyh lekarstvennyh preparatov [Tekst] / A.N. Vasil'ev // Antibiotiki i himioterapiya.- 2012.- T. 57.- № 1-2.- S. 41-49. URL: https://www.antibiotics-chemotherapy.ru/jour/article/view/421.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">3, Васильев А.Н., Клинические исследования. Методология разработки и принципы проведения [Текст] / А.Н. Васильев, Р.Р. Ниязов, Е.Ю. Парфенова и др. //  Ведомости Научного центра экспертизы средств медицинского применения.- 2012.- №4.- С. 19-25. URL: https://cyberleninka.ru/article/n/klinicheskie-issledovaniya-metodologiya-razrabotki-i-printsipy-provedeniya/viewer.</mixed-citation>
     <mixed-citation xml:lang="en">3, Vasil'ev A.N., Klinicheskie issledovaniya. Metodologiya razrabotki i principy provedeniya [Tekst] / A.N. Vasil'ev, R.R. Niyazov, E.Yu. Parfenova i dr. //  Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya.- 2012.- №4.- S. 19-25. URL: https://cyberleninka.ru/article/n/klinicheskie-issledovaniya-metodologiya-razrabotki-i-printsipy-provedeniya/viewer.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Добровольский А.В.  Подходы к клинической разработке комбинированных препаратов в Российской Федерации и Европейском экономическом союзе с учетом требований действующего законодательства [Текст] / А.В. Добровольский // Ведомости Научного центра экспертизы средств медицинского применения.- 2019.- Т. 9. - № 1.- С. 14-27. URL: https://www.vedomostincesmp.ru/jour/article/view/208.</mixed-citation>
     <mixed-citation xml:lang="en">Dobrovol'skiy A.V.  Podhody k klinicheskoy razrabotke kombinirovannyh preparatov v Rossiyskoy Federacii i Evropeyskom ekonomicheskom soyuze s uchetom trebovaniy deystvuyuschego zakonodatel'stva [Tekst] / A.V. Dobrovol'skiy // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya.- 2019.- T. 9. - № 1.- S. 14-27. URL: https://www.vedomostincesmp.ru/jour/article/view/208.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Едронова В.Н. Методы, методология и логика научных исследований [Текст] / В.Н. Едронова, В.О. Овчаров // Экономический анализ: теория и практика.- 2013.- № 9(312).- С. 14-23. URL: https://www.fin-izdat.ru/journal/analiz/detail.php?ID=55538.</mixed-citation>
     <mixed-citation xml:lang="en">Edronova V.N. Metody, metodologiya i logika nauchnyh issledovaniy [Tekst] / V.N. Edronova, V.O. Ovcharov // Ekonomicheskiy analiz: teoriya i praktika.- 2013.- № 9(312).- S. 14-23. URL: https://www.fin-izdat.ru/journal/analiz/detail.php?ID=55538.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Едронова В.Н. Система методов в научных исследованиях [Текст] / В.Н. Едронова, В.О. Овчаров //  Экономический анализ: теория и практика.- 2013.- № 10(313).- С. 33-47. URL: https://www.fin-izdat.ru/journal/analiz/detail.php?ID=55642.</mixed-citation>
     <mixed-citation xml:lang="en">Edronova V.N. Sistema metodov v nauchnyh issledovaniyah [Tekst] / V.N. Edronova, V.O. Ovcharov //  Ekonomicheskiy analiz: teoriya i praktika.- 2013.- № 10(313).- S. 33-47. URL: https://www.fin-izdat.ru/journal/analiz/detail.php?ID=55642.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Енгалычева Г.Н. Экспертная оценка доклинических исследований первичной и вторичной фармакодинамики лекарственных средств [Текст] / Г.Н. Енгалычева, Р.Д. Сюбаев, Д.В. Горячев, Ю.В. Олефир // Ведомости Научного центра экспертизы средств медицинского применения.- 2018.- Т. 8.- № 3.- С. 138-144. URL: https://www.vedomostincesmp.ru/jour/article/view/174/168.</mixed-citation>
     <mixed-citation xml:lang="en">Engalycheva G.N. Ekspertnaya ocenka doklinicheskih issledovaniy pervichnoy i vtorichnoy farmakodinamiki lekarstvennyh sredstv [Tekst] / G.N. Engalycheva, R.D. Syubaev, D.V. Goryachev, Yu.V. Olefir // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya.- 2018.- T. 8.- № 3.- S. 138-144. URL: https://www.vedomostincesmp.ru/jour/article/view/174/168.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Руководство по экспертизе лекарственных средств для медицинского применения. М: ГОЭТАР. 2022. 164 с. URL: https://www.regmed.ru/upload/iblock/eee/ni9gqb04jn1c4qwatet0wlxofb8fli0w/%D0%A0%D1%83%D0%BA%D0%BE%D0%B2%D0%BE%D0%B4%D1%81%D1%82%D0%B2%D0%BE%20%D0%BF%D0%BE%20%D1%8D%D0%BA%D1%81%D0%BF%D0%B5%D1%80%D1%82%D0%B8%D0%B7%D0%B5%20%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D1%85%20%D1%81%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B2%20%D0%B4%D0%BB%D1%8F%20%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%BE%D0%B3%D0%BE%20%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D0%B5%D0%BD%D0%B8%D1%8F.pdf.</mixed-citation>
     <mixed-citation xml:lang="en">Rukovodstvo po ekspertize lekarstvennyh sredstv dlya medicinskogo primeneniya. M: GOETAR. 2022. 164 s. URL: https://www.regmed.ru/upload/iblock/eee/ni9gqb04jn1c4qwatet0wlxofb8fli0w/%D0%A0%D1%83%D0%BA%D0%BE%D0%B2%D0%BE%D0%B4%D1%81%D1%82%D0%B2%D0%BE%20%D0%BF%D0%BE%20%D1%8D%D0%BA%D1%81%D0%BF%D0%B5%D1%80%D1%82%D0%B8%D0%B7%D0%B5%20%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D1%85%20%D1%81%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B2%20%D0%B4%D0%BB%D1%8F%20%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%BE%D0%B3%D0%BE%20%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D0%B5%D0%BD%D0%B8%D1%8F.pdf.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Guidelines on Repeated Dose Toxicity. Committee on Human Medicinal Products (CPMP/CWP/1042/99 Rev 1 Сorr*. [Электронный ресурс] URL: http://www.ema.europa.eu/docx/en_GB/document_library/Scientific_guideline/2010/03/WC500079536_pdf (дата обращения 29.11.2011).</mixed-citation>
     <mixed-citation xml:lang="en">Guidelines on Repeated Dose Toxicity. Committee on Human Medicinal Products (CPMP/CWP/1042/99 Rev 1 Sorr*. [Elektronnyy resurs] URL: http://www.ema.europa.eu/docx/en_GB/document_library/Scientific_guideline/2010/03/WC500079536_pdf (data obrascheniya 29.11.2011).</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">The Common Technical Document of the Registration of Pharmaceuticals for Human Use: Safety – M45(R2). Nonclinical overview and nonclinical summaries of module 2 organization of module 4. [Электронный ресурс]. URL: http:// www.Ich.org/fileadmin Public WebSite/ICH Products CTD/M4_R2_Safety/M45_R2_pdf (дата обращения 28.11.2011).</mixed-citation>
     <mixed-citation xml:lang="en">The Common Technical Document of the Registration of Pharmaceuticals for Human Use: Safety – M45(R2). Nonclinical overview and nonclinical summaries of module 2 organization of module 4. [Elektronnyy resurs]. URL: http:// www.Ich.org/fileadmin Public WebSite/ICH Products CTD/M4_R2_Safety/M45_R2_pdf (data obrascheniya 28.11.2011).</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Vrijens B. Current situation of medication adherence in hypertension [Текст] / B. Vrijens, S. Antoniou, M. Burnier et al. // Frontiers in Pharmacology.- 2018.- Vol. 100.- N 8. URL: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00100/full.</mixed-citation>
     <mixed-citation xml:lang="en">Vrijens B. Current situation of medication adherence in hypertension [Tekst] / B. Vrijens, S. Antoniou, M. Burnier et al. // Frontiers in Pharmacology.- 2018.- Vol. 100.- N 8. URL: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00100/full.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Vasil'ev A.N. Kachestvennye doklinicheskie issledovaniya – neobhodimyy etap razrabotki i vnedreniya v klinicheskuyu praktiku novyh lekarstvennyh preparatov [Tekst] / A.N. Vasil'ev // Antibiotiki i himioterapiya.- 2012.- T. 57.- № 1-2.- S. 41-49. URL: https://www.antibioticschemotherapy.ru/jour/article/view/421. 3, Vasil'ev A.N., Klinicheskie issledovaniya. Metodologiya razrabotki i principy provedeniya [Tekst] / A.N. Vasil'ev, R.R. Niyazov, E.Yu. Parfenova i dr. // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya.- 2012.- №4.- S. 19-25. URL: https://cyberleninka.ru/article/n/klinicheskie-issledovaniya-metodologiya-razrabotkii-printsipy-provedeniya/viewer.</mixed-citation>
     <mixed-citation xml:lang="en">Vasil'ev A.N. Kachestvennye doklinicheskie issledovaniya – neobhodimyy etap razrabotki i vnedreniya v klinicheskuyu praktiku novyh lekarstvennyh preparatov [Tekst] / A.N. Vasil'ev // Antibiotiki i himioterapiya.- 2012.- T. 57.- № 1-2.- S. 41-49. URL: https://www.antibioticschemotherapy.ru/jour/article/view/421. 3, Vasil'ev A.N., Klinicheskie issledovaniya. Metodologiya razrabotki i principy provedeniya [Tekst] / A.N. Vasil'ev, R.R. Niyazov, E.Yu. Parfenova i dr. // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya.- 2012.- №4.- S. 19-25. URL: https://cyberleninka.ru/article/n/klinicheskie-issledovaniya-metodologiya-razrabotkii-printsipy-provedeniya/viewer.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Dobrovol'skiy A.V. Podhody k klinicheskoy razrabotke kombinirovannyh preparatov v Rossiyskoy Federacii i Evropeyskom ekonomicheskom soyuze s uchetom trebovaniy deystvuyuschego zakonodatel'stva [Tekst] / A.V. Dobrovol'skiy // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya.- 2019.- T. 9. - № 1.- S. 14-27. URL: https://www.vedomostincesmp.ru/jour/article/view/208.</mixed-citation>
     <mixed-citation xml:lang="en">Dobrovol'skiy A.V. Podhody k klinicheskoy razrabotke kombinirovannyh preparatov v Rossiyskoy Federacii i Evropeyskom ekonomicheskom soyuze s uchetom trebovaniy deystvuyuschego zakonodatel'stva [Tekst] / A.V. Dobrovol'skiy // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya.- 2019.- T. 9. - № 1.- S. 14-27. URL: https://www.vedomostincesmp.ru/jour/article/view/208.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Edronova V.N. Metody, metodologiya i logika nauchnyh issledovaniy [Tekst] / V.N. Edronova, V.O. Ovcharov // Ekonomicheskiy analiz: teoriya i praktika.2013.- № 9(312).- S. 14-23. URL: https://www.finizdat.ru/journal/analiz/detail.php?ID=55538.</mixed-citation>
     <mixed-citation xml:lang="en">Edronova V.N. Metody, metodologiya i logika nauchnyh issledovaniy [Tekst] / V.N. Edronova, V.O. Ovcharov // Ekonomicheskiy analiz: teoriya i praktika.2013.- № 9(312).- S. 14-23. URL: https://www.finizdat.ru/journal/analiz/detail.php?ID=55538.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Edronova V.N. Sistema metodov v nauchnyh issledovaniyah [Tekst] / V.N. Edronova, V.O. Ovcharov // Ekonomicheskiy analiz: teoriya i praktika.- 2013.- № 10(313).- S. 33-47. URL: https://www.finizdat.ru/journal/analiz/detail.php?ID=55642.</mixed-citation>
     <mixed-citation xml:lang="en">Edronova V.N. Sistema metodov v nauchnyh issledovaniyah [Tekst] / V.N. Edronova, V.O. Ovcharov // Ekonomicheskiy analiz: teoriya i praktika.- 2013.- № 10(313).- S. 33-47. URL: https://www.finizdat.ru/journal/analiz/detail.php?ID=55642.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Engalycheva G.N. Ekspertnaya ocenka doklinicheskih issledovaniy pervichnoy i vtorichnoy farmakodinamiki lekarstvennyh sredstv [Tekst] / G.N. Engalycheva, R.D. Syubaev, D.V. Goryachev, Yu.V. Olefir // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya.- 2018.- T. 8.- № 3.- S. 138-144. URL: https://www.vedomostincesmp.ru/jour/article/view/174/168.</mixed-citation>
     <mixed-citation xml:lang="en">Engalycheva G.N. Ekspertnaya ocenka doklinicheskih issledovaniy pervichnoy i vtorichnoy farmakodinamiki lekarstvennyh sredstv [Tekst] / G.N. Engalycheva, R.D. Syubaev, D.V. Goryachev, Yu.V. Olefir // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya.- 2018.- T. 8.- № 3.- S. 138-144. URL: https://www.vedomostincesmp.ru/jour/article/view/174/168.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rukovodstvo po ekspertize lekarstvennyh sredstv dlya medicinskogo primeneniya. M: GOETAR. 2022. 164 s. URL: https://www.regmed.ru/upload/iblock/eee/ni9gqb04jn1c4qwatet0wlxofb8fli0w/%D0 %A0%D1%83%D0%BA%D0%BE%D0%B2%D0%BE%D0%B4%D1%81%D1%8 2%D0%B2%D0%BE%20%D0%BF%D0%BE%20%D1%8D%D0%BA%D1%81% D0%BF%D0%B5%D1%80%D1%82%D0%B8%D0%B7%D0%B5%20%D0%BB% D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0% BD%D0%BD%D1%8B%D1%85%20%D1%81%D1%80%D0%B5%D0%B4%D1% 81%D1%82%D0%B2%20%D0%B4%D0%BB%D1%8F%20%D0%BC%D0%B5% D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%BE%D0 %B3%D0%BE%20%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D 0%B5%D0%BD%D0%B8%D1%8F.pdf.</mixed-citation>
     <mixed-citation xml:lang="en">Rukovodstvo po ekspertize lekarstvennyh sredstv dlya medicinskogo primeneniya. M: GOETAR. 2022. 164 s. URL: https://www.regmed.ru/upload/iblock/eee/ni9gqb04jn1c4qwatet0wlxofb8fli0w/%D0 %A0%D1%83%D0%BA%D0%BE%D0%B2%D0%BE%D0%B4%D1%81%D1%8 2%D0%B2%D0%BE%20%D0%BF%D0%BE%20%D1%8D%D0%BA%D1%81% D0%BF%D0%B5%D1%80%D1%82%D0%B8%D0%B7%D0%B5%20%D0%BB% D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0% BD%D0%BD%D1%8B%D1%85%20%D1%81%D1%80%D0%B5%D0%B4%D1% 81%D1%82%D0%B2%20%D0%B4%D0%BB%D1%8F%20%D0%BC%D0%B5% D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%BE%D0 %B3%D0%BE%20%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D 0%B5%D0%BD%D0%B8%D1%8F.pdf.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Guidelines on Repeated Dose Toxicity. Committee on Human Medicinal Products (CPMP/CWP/1042/99 Rev 1 Sorr*. [Elektronnyy resurs] URL: http://www.ema.europa.eu/docx/en_GB/document_library/Scientific_guideline/2010/ 03/WC500079536_pdf (data obrascheniya 29.11.2011).</mixed-citation>
     <mixed-citation xml:lang="en">Guidelines on Repeated Dose Toxicity. Committee on Human Medicinal Products (CPMP/CWP/1042/99 Rev 1 Sorr*. [Elektronnyy resurs] URL: http://www.ema.europa.eu/docx/en_GB/document_library/Scientific_guideline/2010/ 03/WC500079536_pdf (data obrascheniya 29.11.2011).</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">The Common Technical Document of the Registration of Pharmaceuticals for Human Use: Safety – M45(R2). Nonclinical overview and nonclinical summaries of module 2 organization of module 4. [Elektronnyy resurs]. URL: http:// www.Ich.org/fileadmin Public WebSite/ICH Products CTD/M4_R2_Safety/M45_R2_pdf (data obrascheniya 28.11.2011).</mixed-citation>
     <mixed-citation xml:lang="en">The Common Technical Document of the Registration of Pharmaceuticals for Human Use: Safety – M45(R2). Nonclinical overview and nonclinical summaries of module 2 organization of module 4. [Elektronnyy resurs]. URL: http:// www.Ich.org/fileadmin Public WebSite/ICH Products CTD/M4_R2_Safety/M45_R2_pdf (data obrascheniya 28.11.2011).</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Vrijens B. Current situation of medication adherence in hypertension [Tekst] / B. Vrijens, S. Antoniou, M. Burnier et al. // Frontiers in Pharmacology.- 2018.- Vol. 100.N 8. URL: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.0010 0/full.</mixed-citation>
     <mixed-citation xml:lang="en">Vrijens B. Current situation of medication adherence in hypertension [Tekst] / B. Vrijens, S. Antoniou, M. Burnier et al. // Frontiers in Pharmacology.- 2018.- Vol. 100.N 8. URL: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.0010 0/full.</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
